Business
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the William Blair 46th Annual Growth Stock Conference. Management will present from 12:40pm to 1:10pm Central Time on Tuesday, June 2, 2026. A live and archived webcast will be available on the “Events & Presentations” page
About this update from Billiontoone, Inc.
[{"type":"image","alt":"BillionToOne, Inc.","displaySize":"","headline":null,"caption":"BillionToOne, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":158,"url":"https://media.zenfs.com/en/globenewswire.com/a8773d444a4068c16414f95fd9063401"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OuPNjYFStlDgDxnpn2wC9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMQ--/https://media.zenfs.com/en/globenewswire.com/a8773d444a4068c16414f95fd9063401","width":300,"height":158},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/OuPNjYFStlDgDxnpn2wC9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMQ--/https://media.zenfs.com/en/globenewswire.com/a8773d444a4068c16414f95fd9063401","width":300,"height":158}},"lazy":false},{"type":"text","content":"MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the William Blair 46th Annual Growth Stock Conference.","length":331,"tagName":"p"},{"type":"text","content":"Management will present from 12:40pm to 1:10pm Central Time on Tuesday, June 2, 2026.","length":85,"tagName":"p"},{"type":"text","content":"A live and archived webcast will be available on the “Events & Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.","length":203,"tagName":"p"},{"type":"text","content":"About BillionToOne","length":18,"tagName":"p"},{"type":"text","content":"Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level.","length":367,"tagName":"p"},{"type":"text","content":"Investor [email protected]","length":36,"tagName":"p"},{"type":"text","content":"Media [email protected]","length":43,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"}]